ArticleJCO precision oncology2021

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.

Fotios Loupakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.